Developer docs
API playgroundTry for free, no card

Search company profiles

Kutxa Fundazioa

Full company profile

uuid00cgtvu

Namestring
Kutxa Fundazioa
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Kutxa Fundazioa is a Basque foundation headquartered in Donostia-San Sebastián, Spain. Its stated mission is to contribute to strengthening a sustainable, competitive, and innovative business network in Gipuzkoa. The organization operates as an institutional investor and capital partner to companies in the Basque Country rather than as a product or service vendor; no commercial products, platforms, or revenue mechanics are disclosed in available sources.

The foundation's recent investment activity has been concentrated in the biotechnology and advanced oncology sector, most visibly through two reported capital commitments to ONCOMATRYX — €15 million within a €58 million capital increase (reported 2026-03-23) and $18 million within a $67 million funding round (reported 2026-03-30) — to support the development of Quantum Antibody-Drug Conjugates (ADCs) for metastatic solid tumors, Phase 1B-2A clinical advancement of lead candidate OMTX705, and the establishment of an integrated Fill & Finish manufacturing plant for high-potency oncology drugs in Gipuzkoa. These checks place Kutxa Fundazioa alongside a coordinated Basque and Spanish institutional syndicate that includes CDTI/Innvierte (€24.3M), the Basque Government, Ekarpen VC, and BBK (€2M).

Kutxa Fundazioa's business model is that of a regional anchor institutional investor rather than a revenue-generating enterprise. Pricing, go-to-market, customer segments, and headcount are not disclosed in available sources, and the inputs do not describe a product surface or technology stack owned by the foundation. Its commercial relevance is exercised through equity participation, partnership formation, and capital deployment in strategic Basque industrial capabilities, principally biopharma manufacturing.

Short descriptiontext

Kutxa Fundazioa is a Basque foundation based in Donostia-San Sebastián, Spain, that acts as an institutional investor to strengthen Gipuzkoa's innovation economy, with recent capital concentrated in regional biotech, including ONCOMATRYX.

Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
HeadquartersDonostia-san Sebastián, Spain
HQ citystring
Donostia-san Sebastián
HQ countrystring
Spain
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
institutional venture capital, foundation investment, biotech equity funding, regional development finance, public-private partnership
Industry3 codes
1HoldCo / Permanent Capital ETA
CodeFSANALAEPrimaryYes
2Impact Investment & Development Investment Funds
CodeBPADACAOPrimaryNo
3Private Sector & Blended Finance Arms (IFC-type)
CodeBPADACAJPrimaryNo
NAICS code2 codes
  • Other Investment Pools and Funds5259
  • Funds, Trusts, and Other Financial Vehicles525
SIC code1 code
  • Investment Advice6282
Product category
Institutional Investment and Foundation Capital
No data
Cost components3 values
Operations, Personnel, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Kutxa Fundazioa is a Basque foundation that deploys institutional capital into companies to strengthen a sustainable, competitive, and innovative business network in Gipuzkoa. Its core activity is participating in equity funding rounds — evidenced by €15 million and $18 million investments in ONCOMATRYX — alongside the Spanish Government, the Basque Government, Ekarpen VC, and BBK. The foundation focuses on strategic sectors such as biotechnology and advanced oncology therapeutics.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Kutxa Fundazioa is a Basque foundation that operates as an institutional investment entity. Based on the available source data, there is no product or service offering described. The organization is identified through its investment activities in biotechnology companies, specifically its participation in funding rounds for ONCOMATRYX. No products, services, platforms, or modules are detailed in the source material.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeRegional player
Description

Italian banking foundation operating in Piedmont with venture, impact, and territorial development mandates. Comparable as a regional European foundation deploying permanent capital into local enterprise and innovation ecosystems.

TypeDirect peer
Description

Basque Government agency implementing industrial policy and supporting Basque firms, often through co-investment with foundations like Kutxa Fundazioa. Comparable as a regional development investor with overlapping portfolio companies and mandates.

TypeBroad incumbent
Description

EU-level fund-of-funds investor providing VC mandates and cornerstone commitments across Europe. Comparable to Kutxa Fundazioa as an institutional LP/anchor in regional VC and growth rounds, though at a much larger scale and broader geographic scope.

TypeBroad incumbent
Description

Spain's national promotional bank, offering credit, venture debt, and equity lines to Spanish companies. It is a broader incumbent in the same institutional-investment space and frequently co-invests with regional actors like Kutxa Fundazioa in large domestic deals.

TypeRegional player
Description

Portuguese foundation active in scientific research and innovation investment across Portugal and beyond. Comparable in legal form (foundation), scale of permanent capital, and focus on catalysing regional innovation capacity.

TypeRegional player
Description

Major Italian banking-origin foundation investing in innovation, research, and social impact across Lombardy. Comparable in legal form (foundation), permanent capital structure, and mission of strengthening a regional innovation ecosystem — analogous to Kutxa Fundazioa's Basque mandate.

TypeRegional player
Description

Major French philanthropic foundation deploying capital into social and innovation causes nationally. Comparable as a permanent-capital foundation with an institutional investment arm supporting enterprise development in its home region.

TypeDirect peer
Description

Spanish public R&D financing entity that co-invested €24.3M in the ONCOMATRYX round alongside Kutxa Fundazioa. It is the most direct peer as it shares the same institutional investor role in Spanish biotech and operates the same public-private partnership structure.

TypeDirect peer
Description

Sister Basque savings bank foundation that contributed €2M to the same ONCOMATRYX round. Highly comparable — same legal form (foundation), same regional mandate (Basque Country), and similar institutional investor role in regional enterprise.

TypeDirect peer
Description

Basque Government-affiliated VC firm that co-invested €10.5M in ONCOMATRYX alongside Kutxa Fundazioa. Comparable as a regional institutional investor in Basque growth-stage companies with similar ticket sizes and co-investment roles.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment5 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Kutxa Fundazioa

Institutional Investment and Foundation Capitalkutxafundazioa.eus

Kutxa Fundazioa is a Basque foundation based in Donostia-San Sebastián, Spain, that acts as an institutional investor to strengthen Gipuzkoa's innovation economy, with recent capital concentrated in regional biotech, including ONCOMATRYX.

What Kutxa Fundazioa does

Kutxa Fundazioa is a Basque foundation headquartered in Donostia-San Sebastián, Spain. Its stated mission is to contribute to strengthening a sustainable, competitive, and innovative business network in Gipuzkoa. The organization operates as an institutional investor and capital partner to companies in the Basque Country rather than as a product or service vendor; no commercial products, platforms, or revenue mechanics are disclosed in available sources.

The foundation's recent investment activity has been concentrated in the biotechnology and advanced oncology sector, most visibly through two reported capital commitments to ONCOMATRYX — €15 million within a €58 million capital increase (reported 2026-03-23) and $18 million within a $67 million funding round (reported 2026-03-30) — to support the development of Quantum Antibody-Drug Conjugates (ADCs) for metastatic solid tumors, Phase 1B-2A clinical advancement of lead candidate OMTX705, and the establishment of an integrated Fill & Finish manufacturing plant for high-potency oncology drugs in Gipuzkoa. These checks place Kutxa Fundazioa alongside a coordinated Basque and Spanish institutional syndicate that includes CDTI/Innvierte (€24.3M), the Basque Government, Ekarpen VC, and BBK (€2M).

Kutxa Fundazioa's business model is that of a regional anchor institutional investor rather than a revenue-generating enterprise. Pricing, go-to-market, customer segments, and headcount are not disclosed in available sources, and the inputs do not describe a product surface or technology stack owned by the foundation. Its commercial relevance is exercised through equity participation, partnership formation, and capital deployment in strategic Basque industrial capabilities, principally biopharma manufacturing.

Kutxa Fundazioa firmographics

Firmographics
Name
Kutxa Fundazioa
Website
https://kutxafundazioa.eus
Company type
Private
Operating status
Operating
Short description
Kutxa Fundazioa is a Basque foundation based in Donostia-San Sebastián, Spain, that acts as an institutional investor to strengthen Gipuzkoa's innovation economy, with recent capital concentrated in regional biotech, including ONCOMATRYX.
Ownership category
akta.pro rank

Kutxa Fundazioa industry classification

Industry
Product category
Institutional Investment and Foundation Capital
NAICS
Other Investment Pools and Funds (5259), Funds, Trusts, and Other Financial Vehicles (525)
SIC
Investment Advice (6282)
akta.pro primary industry
HoldCo / Permanent Capital ETA (FSANALAE)
akta.pro secondary industries
Impact Investment & Development Investment Funds (BPADACAO), Private Sector & Blended Finance Arms (IFC-type) (BPADACAJ)

Keywords

  • Institutional venture capital
  • Foundation investment
  • Biotech equity funding
  • Regional development finance
  • Public-private partnership

Where Kutxa Fundazioa is headquartered

Location

Headquarters

HQ city
Donostia-san Sebastián
HQ country
Spain
HQ region
Europe

Markets served

Kutxa Fundazioa business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Operations, Personnel, Others

Kutxa Fundazioa product offering

Product offering

Core offering

Kutxa Fundazioa is a Basque foundation that deploys institutional capital into companies to strengthen a sustainable, competitive, and innovative business network in Gipuzkoa. Its core activity is participating in equity funding rounds — evidenced by €15 million and $18 million investments in ONCOMATRYX — alongside the Spanish Government, the Basque Government, Ekarpen VC, and BBK. The foundation focuses on strategic sectors such as biotechnology and advanced oncology therapeutics.

Product overview

Kutxa Fundazioa is a Basque foundation that operates as an institutional investment entity. Based on the available source data, there is no product or service offering described. The organization is identified through its investment activities in biotechnology companies, specifically its participation in funding rounds for ONCOMATRYX. No products, services, platforms, or modules are detailed in the source material.

Differentiator

Problem solved

Functional benefit

Companies that use Kutxa Fundazioa

Customer profile

Ideal customer profiles1 record

Kutxa Fundazioa technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Kutxa Fundazioa partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves4 records

Expansion highlights3 records

Kutxa Fundazioa competitors and assessment

Company assessment

Regional players

  • Fondazione CRT: Italian banking foundation operating in Piedmont with venture, impact, and territorial development mandates. Comparable as a regional European foundation deploying permanent capital into local enterprise and innovation ecosystems.
  • Calouste Gulbenkian Foundation: Portuguese foundation active in scientific research and innovation investment across Portugal and beyond. Comparable in legal form (foundation), scale of permanent capital, and focus on catalysing regional innovation capacity.
  • Fondazione Cariplo: Major Italian banking-origin foundation investing in innovation, research, and social impact across Lombardy. Comparable in legal form (foundation), permanent capital structure, and mission of strengthening a regional innovation ecosystem — analogous to Kutxa Fundazioa's Basque mandate.
  • Fondation de France: Major French philanthropic foundation deploying capital into social and innovation causes nationally. Comparable as a permanent-capital foundation with an institutional investment arm supporting enterprise development in its home region.

Direct peers

  • SPRI (Basque Business Development Agency): Basque Government agency implementing industrial policy and supporting Basque firms, often through co-investment with foundations like Kutxa Fundazioa. Comparable as a regional development investor with overlapping portfolio companies and mandates.
  • CDTI (Centro para el Desarrollo Tecnológico e Industrial): Spanish public R&D financing entity that co-invested €24.3M in the ONCOMATRYX round alongside Kutxa Fundazioa. It is the most direct peer as it shares the same institutional investor role in Spanish biotech and operates the same public-private partnership structure.
  • BBK (Bilbao Bizkaia Kutxa Fundazioa): Sister Basque savings bank foundation that contributed €2M to the same ONCOMATRYX round. Highly comparable — same legal form (foundation), same regional mandate (Basque Country), and similar institutional investor role in regional enterprise.
  • Ekarpen VC: Basque Government-affiliated VC firm that co-invested €10.5M in ONCOMATRYX alongside Kutxa Fundazioa. Comparable as a regional institutional investor in Basque growth-stage companies with similar ticket sizes and co-investment roles.

Broad incumbents

  • European Investment Fund (EIF): EU-level fund-of-funds investor providing VC mandates and cornerstone commitments across Europe. Comparable to Kutxa Fundazioa as an institutional LP/anchor in regional VC and growth rounds, though at a much larger scale and broader geographic scope.
  • ICO (Instituto de Crédito Oficial): Spain's national promotional bank, offering credit, venture debt, and equity lines to Spanish companies. It is a broader incumbent in the same institutional-investment space and frequently co-invests with regional actors like Kutxa Fundazioa in large domestic deals.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Kutxa Fundazioa financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Kutxa Fundazioa leadership team

Management profile

Number of profiles

Kutxa Fundazioa funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Kutxa Fundazioa M&A and investment

M&A and investment

M&A

Investments5 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kutxa Fundazioa

What does Kutxa Fundazioa do?

Kutxa Fundazioa is a Basque foundation that deploys institutional capital into companies to strengthen a sustainable, competitive, and innovative business network in Gipuzkoa. Its core activity is participating in equity funding rounds — evidenced by €15 million and $18 million investments in ONCOMATRYX — alongside the Spanish Government, the Basque Government, Ekarpen VC, and BBK. The foundation focuses on strategic sectors such as biotechnology and advanced oncology therapeutics.

Is Kutxa Fundazioa a public or private company?

Kutxa Fundazioa is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Kutxa Fundazioa founded?

Kutxa Fundazioa was founded in -1.

Where is Kutxa Fundazioa based?

Kutxa Fundazioa is headquartered in Donostia-san Sebastián, Spain, in the Europe region.

Who are Kutxa Fundazioa's main competitors?

Regional players on record are Fondazione CRT, Calouste Gulbenkian Foundation, Fondazione Cariplo and Fondation de France. Direct peers are SPRI (Basque Business Development Agency), CDTI (Centro para el Desarrollo Tecnológico e Industrial), BBK (Bilbao Bizkaia Kutxa Fundazioa) and Ekarpen VC. Broad incumbents are European Investment Fund (EIF) and ICO (Instituto de Crédito Oficial).

Does Kutxa Fundazioa have an API?

No public API is recorded for Kutxa Fundazioa.

What industry is Kutxa Fundazioa in?

Kutxa Fundazioa's product category is Institutional Investment and Foundation Capital. Its primary akta.pro industry code is FSANALAE, HoldCo / Permanent Capital ETA, with a secondary code of BPADACAO, Impact Investment & Development Investment Funds. Its NAICS code is 5259 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
WebcapitalriesgoSafeLoc Systems cierra ronda de más de €1,4M cubierta por Kutxa Fundazioa, BeAble y GCRPVSafeLoc Systems, a Basque startup, raised €1.45 million in a funding round led by Kutxa Fundazioa with BeAble Capital and Basque Tek Ventures. The company, valued at €4.5 million, will use the funds to scale its real-time location technology and expand internationally, targeting markets like France, Italy, and Germany.EleconomistaLa startup SafeLoc cierra ronda de más de 1,4 millones de eurosSafeLoc Systems, a Basque startup, raised €1.45 million in funding led by Kutxa Fundazioa, BeAble Capital, and Basque Tek Ventures. The company, valued at €4.5 million, will use the funds to scale its real-time location technology and expand internationally, targeting markets like France, Italy, and Germany.FRENCHWEB.FRLes levées de fonds de la deeptech européenne du 7 au 13 septembre 2026Ten European deeptech companies announced funding rounds from September 7 to 13, 2026, including Mistral AI's €3 billion Series D and The Exploration Company's $450 million Series C. The rounds span AI, space, energy, health, and industrial software, with investors like Samsung, EQT, and the European Investment Bank.KutxafundazioaDeneb Medical impulsa la cirugía robótica de columna respaldada por SETT, Kutxa Fundazioa y una multinacional estadounidense líder en dispositivos médicosDeneb Medical closed a €14.7 million funding round to develop and launch its IZAR robotic spine surgery system. The round includes €7.2 million from SETT, €5 million from a US medical device firm, and €2.5 million from Kutxa Fundazioa. The company will use the funds to accelerate IZAR's market entry and maintain its Donostia headquarters.SalesTech StarMultiverse Computing Announces Series C Fundraising Targeting up to $570M (€500M) to Power Efficient AI from Edge to CloudMultiverse Computing announced a $570 million Series C round at a $1.7 billion pre-money valuation, co-led by Forgepoint Capital, BNPP Solar Impulse, and Bullhound Capital. The round brings total funding to $800 million and funds expansion of its CompactifAI compression technology, which reduces model size by up to 80-95%.BusinessinsiderLa startup vasca Multiverse dispara su valoración hasta los 1.500 millones de euros en su carrera por comprimir la IAMultiverse Computing, a Basque startup, raised 500 million euros in a Series C round led by Forgepoint, BNP, and Bullhound, doubling its valuation to 1.5 billion euros. The company's CompactifAI technology compresses AI models by 95%, enabling faster, cheaper inference. It plans to expand beyond edge devices to AI-integrated computers.FinSMEsOncomatrix Raises $67M in FundingOncomatrix, a biopharmaceutical company based in Derio, Spain, has raised $67 million in a funding round led by institutional investors including the Spanish Government through CDTI ($28M), Kutxa Fundazioa ($18M), the Basque Government and Ekarpen VC ($12M combined), and BBK ($2M), along with private investors. The company plans to use the proceeds to expand its operations and R&D efforts, specifically advancing its Quantum ADC platform that targets cancer-associated fibroblasts in metastatic solid tumors. Phase Ib-II clinical results for OMTX705 are expected to be presented at oncology conferences throughout 2026.OncomatryxKutxa Fundazioa, the Basque Government, and the Spanish Government are driving Oncomatryx’s transformation into a biopharmaceutical company – OncomatryxOncomatryx, a Basque biotech company, has completed a 58 million euro capital increase backed by multiple institutional investors including the Spanish Government (24.3M€ through Innvierte/CDTI), Kutxa Fundazioa (15M€), the Basque Government and Ekarpen (10.5M€), and BBK (2M€), alongside other private investors. The funding will support the company's transition into an integrated biopharmaceutical firm, advance its lead drug OMTX705 through Phase 1B-2A clinical trials, and establish a Fill & Finish manufacturing plant for high-potency oncology drugs in Gipuzkoa. The Spanish and Basque governments describe the investment as part of a public-private partnership to strengthen Spain's position in biotechnology and advanced oncology therapies.CdtiLa SICC Innvierte del CDTI Innovación invierte junto con Orza Gestión y Tenencia de Patrimonios AIE y Kutxa Fundazioa, en Polimerbio, empresa innovadora que fabrica dispositivos médicos biodegradablesCDTI Innovación, through its Innvierte programme, has closed a 450,000-euro investment round in Polimerbio, a biotech company developing biodegradable medical devices, co-investing alongside Orza Gestión y Tenencia de Patrimonios AIE and Kutxa Fundazioa. Polimerbio's devices, based on polymeric biomaterials, are initially focused on treating urethral stenosis, with the aim of reducing surgical interventions and hospital costs while improving patient quality of life. The Innvierte initiative has committed a total of 2,885.8 million euros across 54 investment vehicles to date.